PHA 338 - Transdermal L16

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/90

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 8:37 PM on 6/20/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

91 Terms

1
New cards

What are the major layers of the skin?

Epidermis, dermis, and subcutaneous tissue (hypodermis).

2
New cards

What is the primary barrier and rate-limiting step for percutaneous absorption?

The stratum corneum.

3
New cards

Describe the stratum corneum.

The outer epidermal layer composed of dead keratinized cells (corneocytes) embedded in a lipid matrix.

4
New cards

Describe the dermis.

A 3–5 mm thick connective tissue layer containing collagen, blood vessels, nerves, sweat glands, and hair follicles.

5
New cards

What are Langerhans cells?

The major antigen-presenting cells of the skin.

6
New cards

What is the function of sebaceous glands?

They secrete sebum, which lubricates the skin and helps maintain a surface pH of about 5.

7
New cards

What is topical delivery?

Application of a drug to the skin for local effects.

8
New cards

What is transdermal delivery?

Delivery of a drug through the skin into systemic circulation.

9
New cards

What are examples of conventional dermatological dosage forms?

Gels, lotions, creams, and ointments.

10
New cards

What are the advantages of transdermal delivery?

Avoids first-pass metabolism, provides sustained delivery, is noninvasive, allows self-administration, allows therapy termination by patch removal, reduces adverse effects, and permits multiday therapy.

11
New cards

What are the limitations of passive transdermal delivery?

Works mainly for potent, low-dose, moderately lipophilic, uncharged drugs with low molecular weight and wide therapeutic windows.

12
New cards

Why are potent drugs preferred for transdermal delivery?

Only limited amounts of drug can cross the skin.

13
New cards

Why are low-dose drugs preferred for transdermal delivery?

The skin barrier limits drug delivery.

14
New cards

What type of drug charge is preferred for passive transdermal delivery?

Uncharged.

15
New cards

What lipophilicity is preferred for passive transdermal delivery?

Moderately lipophilic.

16
New cards

What is the ideal log P range for passive transdermal delivery?

1 to 3.5.

17
New cards

What molecular weight is preferred for passive transdermal delivery?

Less than 500 Da.

18
New cards

What daily dose is preferred for passive transdermal delivery?

Less than 10 mg/day.

19
New cards

What solubility is preferred for passive transdermal delivery?

Greater than 100 ÎĽg/mL.

20
New cards

What flux is considered ideal for a transdermal drug?

Approximately 1 mg/cm²/day.

21
New cards

What factors affect percutaneous absorption?

Drug concentration, solubility, partition coefficient, surface area, skin hydration, temperature, application site, penetration enhancers, age, race, and molecular weight.

22
New cards

How does skin hydration affect absorption?

Increased hydration generally increases absorption.

23
New cards

How does temperature affect absorption?

Increased temperature generally increases absorption.

24
New cards

How does surface area affect absorption?

Larger surface area generally increases drug delivery.

25
New cards

Why is the site of application important?

Skin thickness and permeability vary among body sites.

26
New cards

What is a Franz diffusion cell used for?

In vitro evaluation of transdermal drug delivery through skin.

27
New cards

What skin types are commonly used in Franz cell studies?

Human or porcine skin.

28
New cards

What are the two major types of transdermal systems?

Drug-in-adhesive (matrix) systems and reservoir systems.

29
New cards

What is a drug-in-adhesive (DIA) patch?

A patch in which the drug is incorporated directly into the adhesive layer.

30
New cards

What are common adhesive types used in DIA patches?

Acrylate, silicone, and polyisobutylene.

31
New cards

What is a reservoir patch?

A patch containing a drug reservoir separated from the skin by a rate-controlling membrane.

32
New cards

What are the components of a reservoir patch?

Backing, drug reservoir, control membrane, adhesive layer, and protective peel strip.

33
New cards

What controls drug release in a reservoir patch?

The control membrane.

34
New cards

What major problem is associated with reservoir patches?

Leakage.

35
New cards

Which drug had deaths and recalls associated with reservoir patch leakage?

Fentanyl.

36
New cards

Why are some reservoir patches reformulated into matrix patches?

To reduce leakage problems.

37
New cards

What is lag time in transdermal delivery?

The delay between patch application and measurable systemic drug delivery or effect.

38
New cards

Why does lag time occur?

The drug must diffuse through the patch and skin before reaching systemic circulation.

39
New cards

Why may fentanyl patch patients need oral narcotics initially?

Because the patch may require a day or two to reach full effect.

40
New cards

What is the first transdermal product marketed?

Transderm-Scop (scopolamine).

41
New cards

Why is nitroglycerin a good transdermal candidate?

It is potent, has a short half-life, and undergoes extensive first-pass metabolism.

42
New cards

What are nicotine patches used for?

Smoking cessation.

43
New cards

What is the standard nicotine patch schedule?

21 mg/day for 6 weeks, then 14 mg/day for 2 weeks, then 7 mg/day for 2 weeks.

44
New cards

How should nicotine patches be applied?

To a clean, dry, nonhairy area with daily site rotation.

45
New cards

What skin reaction may occur with nicotine patches?

Mild, short-lived erythema.

46
New cards

What should be done in case of nicotine patch overdose?

Remove the patch and flush the area with water; do not use soap.

47
New cards

What can patients do if nicotine patches cause vivid dreams?

Remove the patch at bedtime.

48
New cards

Why must nicotine patches be disposed of properly?

Used patches still contain nicotine.

49
New cards

How should fentanyl patches be applied?

To a dry, flat area; hair may be clipped but not shaved.

50
New cards

What should be avoided while wearing fentanyl patches?

Heating pads and other external heat sources.

51
New cards

Why should heat be avoided with transdermal patches?

Heat can increase drug absorption and cause toxicity.

52
New cards

How is a scopolamine patch used?

Apply behind the ear at least 4 hours before needed and wear for up to 3 days.

53
New cards

What should be done before an MRI when wearing a patch?

Remove the patch.

54
New cards

What body sites are commonly used for patch placement?

Upper arm, back, buttock, and flank.

55
New cards

What body sites should be avoided for patch placement?

Hairy, broken, irritated, or damaged skin.

56
New cards

Why should patch application sites be rotated?

To reduce irritation and improve adhesion.

57
New cards

What should patients avoid touching when applying a patch?

The adhesive surface.

58
New cards

What should be done before applying a new patch?

Remove the old patch.

59
New cards

Should patches be cut?

No.

60
New cards

Should multiple patches be applied to make up for a missed dose?

No.

61
New cards

Why should patches be disposed of carefully?

Residual drug may cause abuse, poisoning, or environmental hazards.

62
New cards

What is crystallization in a transdermal patch?

Formation of drug crystals within the patch matrix over time.

63
New cards

What problems can crystallization cause?

Reduced flux, instability, irritation, and poor appearance.

64
New cards

Which patch was withdrawn because of crystallization problems?

Rotigotine (Neupro).

65
New cards

What polymer was discussed as a crystallization inhibitor?

Polyvinylpyrrolidone (PVP).

66
New cards

What is adhesive failure?

Loss of proper patch adhesion to the skin.

67
New cards

Why is adhesive failure important?

It can result in underdosing, increased cost, and unintended drug exposure.

68
New cards

What is dose dumping?

Rapid release of excessive drug from a dosage form.

69
New cards

What are examples of safety issues with transdermal patches?

Increased absorption from heat, dose dumping, leakage, accidental ingestion, misuse, and MRI burns.

70
New cards

What enhancement technologies can increase drug delivery through skin?

Chemical enhancers, iontophoresis, skin microporation, microneedles, electroporation, sonophoresis, and microdermabrasion.

71
New cards

What is iontophoresis?

Use of electrical current to enhance drug transport through skin.

72
New cards

What is electroporation?

Use of short electrical pulses to increase skin permeability.

73
New cards

What is sonophoresis?

Use of ultrasound to enhance transdermal drug delivery.

74
New cards

What is skin microporation?

Creation of microscopic pores in the skin to improve drug penetration.

75
New cards

What are microneedles?

Microscopic needles that create channels through the stratum corneum.

76
New cards

What is microdermabrasion?

Mechanical disruption of the outer skin layer to improve drug penetration.

77
New cards

What are chemical penetration enhancers?

Chemicals that increase drug movement through the skin.

78
New cards

What sulfoxide penetration enhancer was discussed?

DMSO.

79
New cards

What alcohol penetration enhancer was discussed?

Ethanol.

80
New cards

What glycol penetration enhancer was discussed?

Propylene glycol.

81
New cards

What surfactant penetration enhancer was discussed?

Polysorbate 80.

82
New cards

What terpene penetration enhancer was discussed?

Menthol.

83
New cards

What fatty acid penetration enhancers were discussed?

Oleic acid and isopropyl myristate (IPM).

84
New cards

What does IPM stand for?

Isopropyl myristate.

85
New cards

What does PSA stand for in transdermal formulations?

Pressure-sensitive adhesive.

86
New cards

What is the most important barrier to percutaneous absorption?

The stratum corneum.

87
New cards

What are the key counseling points for transdermal patches?

Apply to clean, dry, intact skin; rotate sites; avoid heat; remove old patch before applying a new one; do not cut patches; dispose of patches properly.

88
New cards
What are the three main categories of enhancement technologies discussed in class?

Chemical enhancers, skin microporation, and iontophoresis.

89
New cards
What are examples of additional enhancement technologies?

Electroporation, sonophoresis, microdermabrasion, microneedles, powder injection, spray mist, prodrugs, eutectic systems, magnetophoresis, and cold plasma.

90
New cards

Stratum corneum

rate-limiting barrier

91
New cards

Ideal transdermal drug

Log P 1–3.5, MW < 500 Da, dose < 10 mg/day, potent, uncharged